Natalizumab in Crohn's disease: Results from a US tertiary inflammatory bowel disease center

Atsushi Sakuraba*, Kian Keyashian, Chase Correia, John Melek, Russell D. Cohen, Stephen B. Hanauer, David T. Rubin

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Natalizumab in Crohn's disease: Results from a US tertiary inflammatory bowel disease center'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

INIS

Immunology and Microbiology

Neuroscience